Genomic Diagnosis of Human Cancer
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Genetic Diagnosis".
Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 2045
Special Issue Editor
Special Issue Information
Dear Colleagues,
Genomic diagnosis of human cancer represents a revolutionary approach to understanding the genetic underpinnings of cancer at a molecular level. It involves the comprehensive analysis of an individual’s genetic information, specifically their DNA, to uncover the genetic mutation and alterations that may drive the development and progression of cancer. This diagnostic approach has significantly advanced our understanding of cancer, leading to more precise and personalized treatments, as well as the potential for early detection and prevention.
Key aspects of the genomic diagnosis of human cancer include genetic profiling, identification of driver mutation, personalized treatment strategies, prognostic insights, therapeutic resistance, early detection and prevention, research and drug development, and ethical and privacy considerations.
Overall, genomic diagnosis has revolutionized our approach to cancer by providing a deeper understanding of the molecular mechanisms that drive the disease. It has paved the way for more personalized and effective cancer treatment, giving hope to patient and researchers alike in the ongoing battle against cancer.
Dr. Yonggang Zhou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarker
- cancer
- DNA methylation
- gene expression
- protein
- NGS